» Articles » PMID: 2928549

Liposomal Gd-DTPA: Preparation and Characterization of Relaxivity

Overview
Journal Radiology
Specialty Radiology
Date 1989 Apr 1
PMID 2928549
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Gadolinium diethylenetriaminepentaacetic acid (DTPA) has not proved particularly useful for hepatosplenic magnetic resonance imaging. However, by entrapping the Gd-DTPA within lipid vesicles, one may exploit the ability of the reticuloendothelial system to endocytose particulates, permitting passive delivery of contrast agent to the liver and spleen while decreasing the rate of clearance of Gd-DTPA from the vasculature. Liposomes of 70-400 nm diameter containing Gd-DTPA were prepared by a freeze-thaw extrusion process. These exhibited high trapping efficiencies and excellent stability during storage. For all sizes of liposomes, the relaxivity of the entrapped Gd-DTPA was less than that of free Gd-DTPA. Relaxivity varied linearly with the surface-area-to-volume ratio of the liposomes; the smaller the liposomes, the greater the relaxivity. Liposomes containing cholesterol had a lower relaxivity than liposomes without cholesterol. The authors suggest this reflects the decrease in the water permeability coefficient caused by the presence of cholesterol in the liposome membrane.

Citing Articles

Synthesis and characterization of Gd-loaded hyaluronic acid-polydopamine nanoparticles as a dual contrast agent for CT and MRI scans.

Shariati A, Ebrahimi T, Babadinia P, Shariati F, Cohan R Sci Rep. 2023; 13(1):4520.

PMID: 36934115 PMC: 10024681. DOI: 10.1038/s41598-023-31252-0.


Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics.

Ray S, Li Z, Hsu C, Hwang L, Lin Y, Chou P Theranostics. 2019; 8(22):6322-6349.

PMID: 30613300 PMC: 6299700. DOI: 10.7150/thno.27828.


Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles.

Arms L, Smith D, Flynn J, Palmer W, Martin A, Woldu A Front Pharmacol. 2018; 9:802.

PMID: 30154715 PMC: 6102329. DOI: 10.3389/fphar.2018.00802.


MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.

Liu X, Madhankumar A, Miller P, Duck K, Hafenstein S, Rizk E Neuro Oncol. 2015; 18(5):691-9.

PMID: 26519740 PMC: 4827043. DOI: 10.1093/neuonc/nov263.


Synthesis and in vivo magnetic resonance imaging evaluation of biocompatible branched copolymer nanocontrast agents.

Jackson A, Chandrasekharan P, Shi J, Rannard S, Liu Q, Yang C Int J Nanomedicine. 2015; 10:5895-907.

PMID: 26425088 PMC: 4583124. DOI: 10.2147/IJN.S88764.